Can dementia be prevented? Experts say yes - here's how to protect your brain
Image: Anna Shvets /pexels
Imagine waking up one morning and forgetting the route to your favourite coffee shop. Or struggling to remember the name of someone you love.
It's a frightening thought, but for millions worldwide, it's a daily reality called dementia. Ahead of World Brain Day on July 22, experts are urging all of us to rethink what we know about brain health.
Forget the myth that dementia is simply an inevitable part of getting older.
According to Dr Patty Francis, president of the Neurological Association of South Africa (NASA), dementia is increasingly the result of decades of exposure to risk factors we can do something about
'Dementia doesn't just arrive overnight,' says Francis. 'It's often rooted in unmanaged issues like high blood pressure, obesity, smoking, depression, diabetes and even chronic stress starting as early as our 30s.'
The statistics from the World Health Organisation (WHO) make it clear why this matters. Right now, around 57 million people live with dementia globally.
By 2030, this number could jump to 78 million, and by 2050, a staggering 153 million. Sub-Saharan Africa, already facing high rates of HIV and stroke (both linked to dementia), is expected to see cases rise from 2.13 million to over 7.6 million in just 25 years.
Yet experts say up to 45% of dementia cases could be prevented by making changes we often underestimate, from staying socially connected to managing medical conditions. Your everyday choices shape your future brain health.
It's tempting to think dementia only concerns older people. But the science shows otherwise. What you do in your 20s, 30s and 40s, diet, exercise, sleep, and even how often you catch up with friends, can dramatically change your risk.
A major Lancet Commission report found that tackling 14 modifiable risk factors, including hearing loss, depression, social isolation, obesity, and diabetes, could prevent or delay almost half of dementia cases worldwide.
Even something as everyday as finishing secondary education, quitting smoking, or getting regular exercise matters.
Video Player is loading.
Play Video
Play
Unmute
Current Time
0:00
/
Duration
-:-
Loaded :
0%
Stream Type LIVE
Seek to live, currently behind live
LIVE
Remaining Time
-
0:00
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
Text Color White Black Red Green Blue Yellow Magenta Cyan
Transparency Opaque Semi-Transparent Background Color Black White Red Green Blue Yellow Magenta Cyan
Transparency Opaque Semi-Transparent Transparent Window Color Black White Red Green Blue Yellow Magenta Cyan
Transparency Transparent Semi-Transparent Opaque
Font Size 50% 75% 100% 125% 150% 175% 200% 300% 400% Text Edge Style None Raised Depressed Uniform Dropshadow Font Family Proportional Sans-Serif Monospace Sans-Serif Proportional Serif Monospace Serif Casual Script Small Caps
Reset
restore all settings to the default values Done
Close Modal Dialog
End of dialog window.
Advertisement
Next
Stay
Close ✕
experts say up to 45% of dementia cases could be prevented by making changes we often underestimate, from staying socially connected to managing medical conditions.
Image: Google DeepMind /pexels
'Every stage of life offers a chance to protect your brain,' says Francis. 'From maternal nutrition and childhood vaccines to managing stress and staying active in midlife."
Warning signs to watch for and why you shouldn't ignore them. Many people dismiss memory lapses or confusion as 'just ageing.'
But spotting symptoms early could change lives. Some common early warning signs include Memory loss that disrupts daily life.
Difficulty doing familiar tasks.
Problems finding words.
Confusion about time or place.
Trouble understanding visual cues.
Losing things and struggling to retrace steps.
Mood swings or personality changes.
Withdrawing from work or social life.
Problems planning or solving problems.
If you or someone you care about notices these, it's vital to see a neurologist or specialist. Some types of dementia, like those linked to vitamin B12 deficiency or HIV, can be treated or even reversed if caught early.
The everyday choices you make influence the future health of your brain.
Image: cottonbro studio /pexels
Beyond medication: the lifestyle power of prevention
While there's currently no cure for Alzheimer's disease, which is the most common type of dementia, experts highlight that early diagnosis, lifestyle changes, and treatment can slow its progression.
Medication to help with thinking and behaviour: Cognitive rehabilitation and occupational therapy
Controlling conditions like high blood pressure or diabetes
'New drugs like anti-amyloid therapies show promise,' Dr Francis explains, 'but they're expensive and not widely available, especially in lower-income countries.'
For most South Africans, early screening, education, and support remain the most powerful tools we have. In many communities, dementia is still stigmatised.
Families often keep quiet, fearing judgment. But Francis believes change starts with conversation.
'We need to see brain health the same way we see heart health,' she says. 'Prioritising it isn't just for later life, it's a lifelong investment.'
The call this World Brain Day is clear: small steps matter. Eating well, getting active, staying connected, and treating medical conditions aren't just about living longer; they're about living better, with minds that stay sharp.
Brain health isn't only for the elderly. It's for everyone, every day. By making simple lifestyle changes today, no matter your age, you could lower your risk tomorrow. Healthy brains build healthy families, healthy communities and a brighter, clearer tomorrow.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Star
8 hours ago
- The Star
WHO announces lenacapavir as a groundbreaking HIV prevention method
Tracy-Lynn Ruiters | Published 1 week ago The World Health Organization (WHO) announced a landmark policy at the 13th International AIDS Society Conference (IAS 2025) on HIV Science in Kigali, Rwanda, releasing new guidelines that recommend injectable lenacapavir (LEN) as a twice-yearly pre-exposure prophylaxis (PrEP) option for HIV prevention. This development has the potential to significantly reshape the global HIV response. LEN is the first twice-yearly injectable PrEP product, offering a highly effective, long-acting alternative to daily oral pills and shorter-acting prevention methods. With just two doses a year, LEN marks a transformative step in HIV prevention, particularly for individuals who face challenges with daily adherence, stigma, or limited access to health care. 'While an HIV vaccine remains elusive, lenacapavir is the next best thing: a long-acting antiretroviral shown in trials to prevent almost all HIV infections among those at risk," said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. 'The launch of WHO's new guidelines, alongside the FDA's recent approval, marks a critical step forward in expanding access to this powerful tool. WHO is committed to working with countries and partners to ensure this innovation reaches communities as quickly and safely as possible.' The new guidelines come at a pivotal time, as global HIV prevention efforts have stalled, with 1.3 million new infections recorded in 2024. Key and priority populations — including sex workers, men who have sex with men, transgender individuals, people who inject drugs, those in prisons, as well as children and adolescents — continue to be disproportionately affected. WHO's endorsement of LEN marks a significant step toward broadening and diversifying HIV prevention strategies, empowering people with more choices to protect their health in ways that align with their needs and circumstances. WHO has recommended a simpler, more accessible approach to HIV testing using rapid tests to support the rollout of long-acting injectable PrEP like LEN and CAB-LA. This change removes a major barrier by cutting out complex, expensive procedures and allowing delivery through local clinics, pharmacies, and tele-health. LEN now joins other WHO-approved HIV prevention options — including daily oral PrEP, injectable cabotegravir, and the dapivirine vaginal ring. Although access to LEN outside clinical trials is still limited, WHO is calling on governments and health partners to begin implementing it within national HIV prevention programmes while gathering data on its real-world use and impact. For the first time, WHO now recommends long-acting injectable cabotegravir and rilpivirine (CAB/RPV) as an option for adults and adolescents who are already virally suppressed on oral antiretroviral therapy (ART) and don't have hepatitis B. This is especially helpful for people who struggle with daily pill-taking. WHO also updated its guidance on inte grating HIV care with other health services, such as treating high blood pressure, diabetes, mental health conditions (like depression, anxiety, and alcohol use disorders), and improving ART adherence. The organisation now recommends STI screening (gonorrhoea and chlamydia) for key and priority populations, even when no symptoms are present. For people living with HIV who have or are at risk of mpox (formerly monkeypox), WHO strongly recommends starting ART quickly, especially if they've never started treatment or have had long interruptions. HIV and syphilis testing is also advised for anyone with suspected or confirmed mpox. Given funding challenges facing global HIV programmes, WHO released new guidance to help countries maintain essential HIV services. This includes advice on how to prioritise services, manage risks, and keep health systems resilient. Dr Meg Doherty, WHO's HIV programme director, emphasised the urgency of acting on these guidelines: 'We have the tools and the knowledge to end AIDS as a public health problem. What we need now is bold implementation of these recommendations, grounded in equity and powered by communities.' HIV continues to be a major public health issue, with an estimated 40.8 million people living with the virus globally by the end of 2024. While treatment access is growing — 31.6 million people are now on ART — new infections and deaths remain high, particularly in the WHO African Region. With these updated guidelines, WHO said it is offering countries practical tools to make HIV responses more efficient, equitable, and sustainable. The focus now shifts to putting these strategies into action. [email protected] Weekend Argus
The Star
8 hours ago
- The Star
Lenacapavir: A game changer for HIV prevention in South Africa
"This is a game changer for South Africa," said Health Minister Aaron Motsoaledi as T he Global Fund to Fight AIDS, Tuberculosis and Malaria on Wednesday secured access to breakthrough HIV prevention for low and middle income countries. "Lenacapavir offers young women, and everyone at risk, a discreet, long-acting option to stay HIV-free. " For far too long, women and girls in our country have carried the greatest burden of this epidemic. "But scientific breakthroughs must be backed by political will, community leadership, and sustained investment. We are determined to ensure no one is left behind.' The deal signed between with US pharmaceutical giant Gilead and the Global Fund will mean lower-income countries will gain access to a the HIV prevention drug at the same time as in high-income countries. There was particular urgency in countries like South Africa, where adolescent girls and young women are disproportionately affected by HIV. The Global Fund said it hoped the agreement with Gilead would make it possible to reach two million people with the drug, which was approved by the US Food and Drug Administration last month. Drugs to prevent HIV transmission, known as pre-exposure prophylaxis or PrEP, have existed for more than a decade. But because they typically require taking a daily pill, they have yet to make a significant dent in global infections.
The Citizen
9 hours ago
- The Citizen
Health budget: R1.7 billion for new staff and millions granted by Gates foundation
Health minister Aaron Motsoaledi announced a R64 billion health budget and a R200 million HIV/ Aids research grant from international funders. The department of health plans to spend billions on recruiting new professionals and infrastructure development over the coming financial year. Health Minister Aaron Motsoaledi announced the coming years' objectives during his budget speech in parliament on Tuesday. The minister added that international organisations will plug the gap left in South Africa's HIV/ Aids programmes by the Pepfar decision. He conceded that the department did not have 'all the money' needed to achieve these objectives, but was in discussions with international and local funders. R64 billion budget Motsoaledi announced that the department had been allocated an overall budget of R64 billion for the 2025/26 financial year. The budget will be used by the department to achieve three main objectives; number one being a laying of the foundations for the National Health Insurance (NHI). 'There are people who believe that we have no plans nor inclination to do that. We want them to listen very attentively,' assured Motsoaledi. Ensuring adequate facilities and sufficient staff would be the backbone of NHI, the minister has earmarked R1.7 billion for the hiring 1 200 doctors and 450 nurses and support staff. A further R1.4 billion will be spent on absorbing 27 000 community health workers who had previously been employed by non-governmental organisations. To 'make public hospitals hospitable', R1.3 billion will be spent on beds, linen, towels, basin and other similar items. Infrastructure upgrade During the last financial year, Motsoaledi boasted that 47 existing clinics and 45 hospitals had been 'substantially' refurbished, while 403 public health facilities had been upgraded. Additionally, five new facilities were completed during the last financial year, and six are currently under construction, and 17 are in the design and development stage. 'These facilities and their placement are not a thumbs-up. We are using a digital system called the Health Infrastructure Portfolio System,' explained the minister. 'This digital system has a geographic information system, district information system and other data tools that help us understand and plan the health system,' he added. The department will also spend R3.75 billion paying accruals — expenses recorded but not paid in earlier financial years — for equipment and pharmaceuticals. The second of Motsoaledi's objectives is to implement 'serious reforms' in the private healthcare system — a goal he did not elaborate on. 'Please ignore those who want us to believe that there is nothing to fix in that sector,' he said. Pepfar replacement Third on Motsoaledi's list is the elimination of diseases such as HIV/ Aids, tuberculosis, malaria and some cancers. 'The time has now arrived to start dreaming about a future with a certain disease gone from our country,' Speaking on the impact of the Pepfar withdrawals, he stated the department would not allow South Africa's HIV programmes to collapse. He said negotiations with treasury had resulted in the allocation of R753 million for provincial and national HIV/ Aids-related support. This will be boosted by R100 million research contributions by both The Bill and Melinda Gates Foundation and London-based researchers the Wellcome Trust. The grants are conditional based on Treasury's commitment to double it, meaning the R200 million from the international funders will be backed by R400 million from Treasury, which is to be released more than three years for HIV/ Aids treatment. Part of this treatment will include the piloting of HIV/ Aids wonderdrug Lenacapavir, a twice-annually injection that claims to have a 100% success rate in preventing HIV/ Aids in women. NOW READ: Health minister weaponising racial bias report to push NHI, says IRR
